Multiple Sclerosis Trial, By Invitation NCT04415372 Sponsor: University of Wisconsin, Madison Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, By Invitation

NCT04415372
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been clinically diagnosed with multiple sclerosis (MS).
  • People between the ages of 18 and 60.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are unable to have an MRI scan for any medical reason.
  • People whose MS treatment has changed in the last 6 months.
  • People who have had a relapse or used corticosteroid medications within the last 6 weeks.
  • People who are currently taking medications that may affect memory or thinking, such as donepezil, rivastigmine, or Adderall.
  • People with a history of significant alcohol or drug abuse.
  • People who are currently experiencing or have a history of significant migraines.
  • People who have another neurological or cognitive condition, such as stroke, Parkinson's disease, Alzheimer's disease, or epilepsy, that could affect the results.
  • People with sensory or physical difficulties that might significantly interfere with cognitive (thinking and memory) testing.
  • People with a history of a developmental or learning disability, or attention-deficit/hyperactivity disorder (ADHD).
  • People who are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 November 2021
Est. completion
1 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Measurement of macromolecular proton content (MPC) by Magnetic resonance imaging

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov